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A newway to study the action of cyclodextrin was developed to quantify the damage caused on cell mem-
brane and lipid bilayer. The Electron Spin Resonance (ESR) spectroscopy was used to study the action of
Randomly methylated-beta-cyclodextrin (Rameb) on living cells (HCT-116). The relative anisotropy
observed in ESR spectrum of nitroxide spin probe (5-DSA and cholestane) is directly related to the rota-
tionalmobility of the probe, which can be further correlatedwith themicroviscosity. The use of ESR probes
clearly shows a close correlation between cholesterol contained in cells and cellular membrane microvis-
cosity. This study also demonstrates the Rameb ability to extract cholesterol and phospholipids in time-
and dose-dependent ways. In addition, ESR spectra enabled to establish that cholesterol is extracted from
lipid rafts to form stable aggregates. The present work supports that ESR is an easy, reproducible and non-
invasive technique to study the effect of cyclodextrins on cell membranes.
























Cyclodextrins (CD) are widely used in the pharmaceutical ﬁeld
and known for their ability to increase the aqueous solubility and
the chemical stability of different drugs [1,2]. There are three types
of natural CDs which are formed by six, seven or eight D-glucopyr-
anose units denominated, respectively as a-, b- and c-CD. These
molecules look like truncated cones constituted by an inner inter-
nal hydrophobic cavity and a hydrophilic surface. Among them, b-
CD derivatives (b-CDs) are known to possess the efﬁcacy to make
complexes with several drugs [1]. Within this family, the Ran-
domly methylated b-CD derivative (Rameb) has received much
attention and has shown a great pharmaceutical interest as it is
efﬁcient for its ability to penetrate through nasal mucosa [3] and
skin [4].
Therefore, Rameb can readily enter in the composition of differ-
ent nasal spray (for instance estradiol nasal spray sold as Aerodiol
in Europe). Even if this kind of CDs is one of the most studied and
commercialized for its ability to enhance drug delivery, Rameb
might still be of a great interest when investigating various
membranes.
Numerous works have demonstrated that the plasma mem-
brane contains different domains [5–9], indicating that membranes





s et al., ESR technique for noni
rc.2010.06.050Singer and Nicholson [10]. Recently, it was highlighted that choles-
terol distribution in the membrane is heterogeneous and concen-
trated in cholesterol- and sphingomyelin-rich domains (lipid
rafts). These lipid rafts are involved in signiﬁcant cell function
and can be isolated in the form of patches resistant to cold non io-
nic detergent [5,11].
However, the existence of these domains is still the subject of
an intense debate in the scientiﬁc community and their morphol-
ogy, size, density and molecular composition are also under con-
sideration. Known for their cholesterol afﬁnity, the b-CDs like
Rameb [3,12] may interact with lipid rafts and could become an
interesting tool to understand the function of lipid rafts.
The most common way to quantify the cholesterol depletion
due to b-CDs is to make a lipid extraction and use a cholesterol as-
say kit [13]. In order to obtain the percentage of cholesterol into
the membrane rafts which are identiﬁed as low density membrane
fraction, a separation of these domains is generally realized by a
sucrose gradient (with or without detergent extraction) [14]. One
of the main disadvantages of the cholesterol extraction is that dif-
ferent amounts of cholesterol are obtained depending on the
experimental protocol used to isolate the membrane [14]. Electron
Spin Resonance (ESR) is a unique technique able to provide infor-
mation about the structure and the dynamics of biological systems
in a noninvasive way [15]. However, despite this great advantage,
no study has been undertaken by ESR to accurately investigate the
interaction between b-CDs and membranes. The present work











































































Fig. 1. Rameb inﬂuence on 5-DSA ESR spectra: (A) 0.001 M 5-DSA in cells
membrane. (B) 0.001 M 5-DSA dissolved in PBS (full line) or in PBS containing
10 mM of CD (dotted line). (C) Spectral ESR evolution of 5-DSA initially embedded
in cell membranes and incubated with 1.5 mM (black line), 2 mM (gray line), 6 mM
(light gray line) and 10 mM of Rameb (dotted line). (D) ESR spectrum of 5-DSA in
the supernatant of cells incubated with 10 mM of CD (full line) and 5-DSA
solubilized in PBS containing 10 mM of CD.
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advantageous tool for a better understanding of these actions on
cell membrane.
2. Materials and methods
2.1. Cell cultures
The human colon carcinoma (HCT-116) cell line was cultured in
Dulbecco’s modiﬁed Eagle’s medium (DMEM, Invitrogen, Belgium)
supplemented with 10% fetal calf serum (Invitrogen, Belgium),
2 mM of L-glutamine, penicillin (100 U/ml), streptomycin (100 U/
ml) (Invitrogen, Belgium) and was maintained in a humidiﬁed
37 C, 5% CO2 incubator. Cells were not used at passages higher
than 20.
2.2. Exposure of HCT-116 cells to Randomly methylated b-cyclodextrin
(Rameb)
Cells from two T175 ﬂasks (90% conﬂuent) were collected by
trypsinization, centrifuged for 7 min at 240g and suspended in
10 ml of medium (DMEM) containing Randomly methylated b-
cyclodextrin (Rameb) which was sterilized by ﬁltration in aseptic
conditions at desired concentration. The cells (15  106) were then
incubated at 37 C for 1 h in a humidiﬁed atmosphere with 5% of
CO2. Rameb was obtained from Wockes Chemie GmbH (Munich,
Germany).
2.3. Cell viability
After 1 and 2 h of Rameb incubation (10 mM), as described
above, cells were centrifuged for 5 min at 200g and the pellet
was resuspended in 10 mM of fresh DMEM. The cell viability was
then determined using both a Cell Proliferation Reagent WST-1
(Roche, Germany) and the Trypan blue dye exclusion assay.
In order to perform the WST-1 cell viability assay according to
the manufacturer instructions [16], the cells (104 cells by well by
100 ll) were placed in microtiter plates (10 min after 1 h period
of incubation). Absorbance of the colored formazan was deter-
mined using an automated microplate reader at 450 nm wave-
length. The mean absorbance of control wells (cells not
incubated with Rameb) represented 100% cell viability. Viability
of cells treated with Rameb was measured in triplicate and com-

















1782.4. Cell sample preparation for ESR measurements
It is known that addition of b-CDs to membrane models expels
phospholipids [3,17,18]. Consequently stearic acid derivative la-
beled by stable doxyl radical ring (n-DSA) is also expelled out of
the cell membrane (see results, Fig. 1). This property helped us to
deﬁne an appropriate protocol in order tomeasure themicroviscos-
ity. The 1 h incubation of cells with Rameb (as described above) was
ended by centrifugation for 5 min at 200g. After dilution of the cell
pellet in 1 ml of sterile phosphate buffer saline solution (PBS), an
amount of stearic acid derivative labeled by stable doxyl radical
ring at the C-5 level (5-DSA) (Aldrich, USA) was added to achieve
104 M concentration and incubated less than 5 min. A 5-DSA stock
solution was ﬁrst obtained in ethanol (102 M) and the added 5-
DSA solution was less than 1% of total volume. Final solutions were
then transferred into a quartz cell (500 ll) for ESR measurements.
3b-Doxyl-5a-cholestane (cholestane) (Sigma, USA) dissolved in
chloroform was also used as a probe on HCT-116 membranes. In
these experiments, collected and centrifuged cells (15  106) were
suspended in 1 ml of PBS containing 104 M cholestane and incu-Please cite this article in press as: A. Grammenos et al., ESR technique for noni
Biophys. Res. Commun. (2010), doi:10.1016/j.bbrc.2010.06.050bated for 10 min. The incubation was ended by the addition of ster-
ilized stock Rameb solution (101 M in PBS) to achieve the ﬁnal
concentration of 2.5  103 M. HCT-116 suspensions were then
transferred into a quartz ﬂat ESR cell.
2.5. Liposome preparation
Lipid vesicles were prepared from Dimyristoylphosphatidylcho-
line (DMPC) (Sigma, USA) and cholesterol (CHOL) (Merck, Ger-
many). Made from DMPC:CHOL (70:30 mol%), the liposomes
were prepared by hydratation of lipid ﬁlms. Brieﬂy, the required
amount of lipids (3.51 mg/mL of DMPC and 0.86 mg/mL of CHOL)
was dissolved in chloroform. The total lipid cholesterol concentra-
tion was 7.4 mM. The mixture was then stirred for 5 min and the
solvent was evaporated under vacuum. The resulting lipid ﬁlm
was suspended in PBS pH 7.0 (1/15 M; Na2HPO4–KH2PO4, from Rie-
del-de Haën, Belgium) at 35 C, and stirred by vortex mixer in order
to obtain large multilamellar vesicles (MLV) [19]. The MLV suspen-
sions were transferred into an extruder (Lipex Biomembrane, Can-
ada), in which the unilamellar liposomes were formed by passing
the suspensions through polycarbonate ﬁlters (0.1 lm pore size,
Nucleopore, CA), under a pressure up to 6895 Pa of nitrogen (Air Li-
quid, Belgium). The procedure was repeated 10 times at 35 C and
resulted in unilamellar liposomes [20]. Once the liposomes were
made, cholestane (stock solution in chloroform (101 M)) was
added and the ﬁnal solution (104 M) was then transferred for
ESR experiments.
2.6. ESR experimental conditions
All ESR experiments were performed at 9.56 GHz using a Bruker
ESR 300E spectrometer (Bruker, Karlshrure-Germany) equipped
with a variable temperature controller accessory and operating at
center ﬁeld strength of 3480 G with 100 G as sweep width, modu-
lation amplitude of 2.55 G and 20.2 mW microwave power. The
time constant and the conversion time were respectively 2.56
and 163.84 ms. Three scans were acquired for each measurement.
2.7. ESR spectra simulation
ESR n-DSA modeling spectra were carried out according to the

































































































Fig. 2. ESR spectra of 5-DSA in the supernatant of cells being in contact with
1.5 mM (A) and 10 mM of Rameb (B). (a) Black line: experimental spectrum. Gray
line: the best ﬁt to the experimental spectrum, taking into account the superim-
position of possible coexisting domains shown in (b). (b) A: computer simulation of
the speciﬁc spectra of the two coexisting domains explored by the 5-DSA: 1; ﬁrst
domain (S = 0.906, s = 0.419 ns, W = 0.702), 2; second domain (S = 0.631,
s = 0.557 ns, W = 1.714). (b) B: computer simulation of the speciﬁc spectrum of
the only one domain (S = 0.028, s = 0.557 ns, W = 0.728) explored by the probe.
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4.99 2005). The spectrum-simulation model assumes that each
spectrum can be a superimposition of the spectral components
that identify the membrane heterogeneity. Each component re-
ﬂects the properties of a particular domain type which is high-
lighted by the values of the chosen parameter set. This one
corresponds to order parameter S, effective rotational correlation
time sc, hyperﬁne and Zeeman tensor’s polarity correction factors
and weighing factors w.
2.8. Microviscosity determination
The mobility of n-DSA in the explored medium (liposomes and
HCT-116 cells) was quantiﬁed by order parameter (S) as described
in point 2.4. In the case of weakly to moderately immobilized
probes (sc < 3  109 s) sc is used, whereas, for strongly immobi-
lized labels (sc > 3  109 s), S is better suited [23,24]. Previously
established standard curves of microviscosity versus correlation
time or order parameter [25] were used to convert measured
parameters into membrane microviscosity. Each measure was re-
peated at least ﬁve times and microviscosity standard deviation
was calculated to be 3%.
2.9. Membrane cholesterol measurement
Cells from two T175 ﬂasks (90% conﬂuent) were collected by
trypsinization, centrifuged for 7 min at 240g and suspended in
10 ml DMEM containing Rameb sterilized by ﬁltration in aseptic
conditions at desired concentration. The cells (15  106) were then
incubated at 37 C for 1 h in a humidiﬁed atmosphere with 5% of
CO2. The 1 h incubation was ended by centrifugation during 5 min
at 200g in order to remove the Rameb. The cell pellet was then sus-
pended in DMEM to be able to count the required amount of cells to
perform a lipidic extraction. Brieﬂy, cells (750,000) were put in con-
tact with 300 ll of 1% Triton distilled in water. After 5 min of incu-
bation, 1.8 ml of a chloroform/methanol (2:1) mixture was added.
The mixture was stirred for 10 min. To obtain a good phase separa-
tion, 300 ll of Tris (0.2 M) at pH 6.5was added, and themixturewas
centrifuged for 10 min (240g) at 37 C. To isolate the lipidic phase,
the chloroform phase was recovered and evaporated under a ﬂow
of nitrogen. The membrane cholesterol levels were then measured
using an Amplex Red Cholesterol Assay Kit according to the manu-
facturer’s instructions (Molecular Probes). Brieﬂy, the membrane
fractions were dissolved within 800 ll of buffer (PBS, pH 7.4) then
incubated with Amplex Red reaction mixture for 30 min at 37 C
and analyzed using a ﬂuorimeter with an excitation wavelength
of 570 nm and emission wavelength of 590 nm.
3. Results and discussion
3.1. Cell viability study
Based on WST-1 assay, ﬂuorometric measurements revealed
that the cell viability was more than 94% after an incubation of
the highest concentration of Rameb (10 mM) for 1 and 2 h (data
not shown). Moreover, at the concentration used to obtain an opti-
mized ESR signal (104 M 5-DSA), no cytotoxic effect of the spin
probe was observed (98% of cell viability). These results were also
conﬁrmed by Trypan blue exclusion assay. It is important to notice
that another type of cell could reveal much higher mortality with
similar concentration of Rameb [13].
3.2. Effects of Rameb on 5-DSA probe
Stearic spin labels (5-DSA) were used as probes to analyze the
interaction between Rameb and the cell membrane ﬂuidity. Spec-Please cite this article in press as: A. Grammenos et al., ESR technique for noni
Biophys. Res. Commun. (2010), doi:10.1016/j.bbrc.2010.06.050trum on Fig. 1A is characteristic of a probe which invested the
hydrophilic cell membrane compartment at 25 C [26].
Fig. 1B highlights the afﬁnity of the 5-DSA with the Rameb. In-
deed, a signiﬁcant difference has been observed between the probe
spectrum in PBS (Fig. 1B, full line) and the one obtained for 5-DSA
in PBS containing Rameb (Fig. 1B, dotted line) which is asymmetric
and distorted; such a spectrum is characteristic of probe aggre-
gates in micelle structures as previously reported [17,27,28].
The addition of increasing concentrations of Rameb (1.5, 2, 6
and 10 mM, respectively) to HCT-116 cells containing 5-DSA in-
duces a progressive transformation of the ESR spectrum (Fig. 1C)
which tends to be similar to the spectrum shown in Fig. 1B (dotted
line). This result reveals that the Rameb afﬁnity with 5-DSA is
strong enough to lead to the extraction of all the probes initially
embedded in the membrane bilayer and that the extracted probe
is not free in solution but aggregates in micellar structure. This
was conﬁrmed by the analysis of the ESR spectrum of the cell
supernatant that has been in contact with Rameb (Fig. 1D, full line)
which is similar to the 5-DSA spectrum in PBS and containing Ra-
meb (Fig. 1D, dotted line).
Fig. 1C also puts in evidence that 5-DSA are extracted in a dose-
dependent way. Indeed, the highest the Rameb concentration is,
the most intense the three peaks of the ESR spectrum are.
A spectral simulation has been done to conﬁrm this behavior
(Fig. 2A-a and B-a, gray line). The simulated spectrum of 5-DSA
incorporated into cell membranes, which were in contact with
1.5 mM of Rameb, corresponds to the addition of two components
characteristic of two different domains. The ﬁrst one (Fig. 2A-1b)
corresponds to probes embedded into the cell membrane and the
second domain (Fig. 2A-2b) to probes extracted from the cell mem-
brane and aggregated within micelles (20% for this Rameb concen-
tration). The spectral simulation obtained with cell membranes in
contact with 10 mM of Rameb has only one component indicating
that all the probes are extracted from the membrane (Fig. 2B-b).
This result is consistent with the fact that Rameb acts in a dose-
dependent manner.
3.3. Effects of Rameb on cholestane probes
The ESR spin labeling method relies on the presence of probes






























































Fig. 4. (A) Inﬂuence of various concentrations of Rameb (0, 0.25, 1, 1.5, 2, 2.5, 6 and
10 mM) on the microviscosity of HCT-116 membranes. Cells have been in contact
with the CD during 1 h at 37 C. (B) Inﬂuence of 6 mM Rameb time exposure on
microviscosity of cell membranes. (C) Residual cholesterol content of HCT-116 after
treatment with various concentrations of Rameb (0, 2, 4, 6, 8 and 10 mM) for 1 h at
37 C.
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ing that the Rameb is able to interact with them. To better appre-
hend the CDs action on membranes another kind of probe has been
used: the cholestane, a membrane spin label with a chemical struc-
ture similar to cholesterol.
Fig. 3A shows the ESR spectrum of cholestane embedded in cell
membrane (light gray line). The large distorted peak observed re-
sults in an important spin–spin nitroxide interaction favoured by
a high local concentration of cholestane. Available knowledge indi-
cates that cellular membranes manage their vast chemical diver-
sity by sorting into specialized microdomains [29] which are
referred to under the general heading of lipid raft. Cholesterol
plays a fundamental role in maintaining their structure and func-
tion [30]. The cholestane spin probe probably lies close to each
other in these lipid rafts, leading to this kind of self-broadening.
To support this hypothesis, DMPC liposomes doped with 30% of
cholesterol and containing cholestane have been prepared
(Fig. 3B). These structures have been made to incorporate the cho-
lesterol uniformaly in the membrane (no raft). The corresponding
ESR spectrum is reported in Fig. 3B; no broad peak as in Fig. 3A
is observed indicating that probes are not close to each other like
in cell membrane. This result tends to conﬁrms that cholesterol
might be organized in rafts within cell membrane and that choles-
tane like cholesterol has an afﬁnity for these microdomains. As
probe and cholesterol have almost similar chemical structure, the
cholestane probably reﬂects the cholesterol behavior.
The evolution of probe ESR spectrum in cells incubated with Ra-
meb (Fig. 3A) clearly demonstrates that cholestane is no more
embedded in membrane. The resulting spectrum is close to the
spectrum of cholestane solubilized in PBS containing Rameb
(Fig. 3C dotted line). The difference between cholestane ESR spec-
trum in PBS and the one obtained in PBS containing Rameb
(Fig. 3C) reﬂects once again the ability of Rameb to form micellar
aggregates with the probes. To sum up, ESR results show that Ra-
meb not only extracts different components from the plasma
membrane to form stable aggregates but it is also able to interact
with lipid rafts.
3.4. Effects of Rameb on membrane microviscosity
As cholesterol and phospholipids are essential constituents of
the membrane, their extraction ought to necessarily affect the de-





















Fig. 3. (A) ESR spectra of cholestane (0.1 mM) in cell membrane (gray line), in cell
membrane being in contact with 2.5 mM of CD (black line) and solubilized in PBS
containing 2.5 mM of CD. (B) Spectrum of cholestane (0.1 mM) embedded in
liposomial bilayer (70:30 mol%). (C) Spectra of cholestane (0.1 mM) solubilized in
PBS (black line) and in PBS containing 2.5 mM of Rameb (dotted line).
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Biophys. Res. Commun. (2010), doi:10.1016/j.bbrc.2010.06.050Fig. 4A shows the microviscosity sensed by 5-DSA probes incor-
porated in HCT-116 cell membrane in function of the Rameb con-
centration. In the absence of Rameb, the microviscosity measured
on HCT-116 membrane, near the polar head group, is 298 cP. This
value decreases as the Rameb concentration increases and stabi-
lizes when reaching 265 cP at 2.5  103 M of cyclodextrin. Up to
102 M of Rameb, the microviscosity remains nearly constant.
Fig. 4B puts in evidence the microviscosity sensed by 5-DSA
probes incorporated in HCT-116 cell membrane as a function of
time exposure for unique Rameb concentration of 6 mM. It appears
that the more the cyclodextrin is in contact with the cells the more
the microviscosity is low. A linear decrease of 35 cP is measured
during the ﬁrst hour.
In order to correlate this microviscosity decrease with the
membrane cholesterol extraction, the membrane cholesterol con-
centration was measured using a cholesterol assay kit.
Fig. 4C shows that the cholesterol concentration of cells without
Rameb is 0.31 ± 0.06 lg/mL. This concentration decreases when
cells were incubated in presence of Rameb. Beyond an exposure
of 6 mM of CD, the cholesterol level remains nearly constant
(0.054 ± 0.011 lg/mL). The comparison between Fig. 4A and C
clearly shows that themicroviscosity and the cellular concentration
of cholesterol decrease with a similar Rameb dose dependence,
supporting the hypothesis that the membrane microviscosity is di-
rectly linked to the cholesterol cell concentration. ESR microviscos-
ity results corroborate our previous work using liposomes as a
membrane model and conﬁrm that the cholesterol extraction due
to the Rameb is the major cause of the membrane microviscosity
decrease [17].
4. Conclusions
This study allows to conﬁrm the ability of Rameb to extract cho-
lesterol and 5-DSA in cells in a dose-dependent way. ESR results
demonstrate that the extracted cholesterol and 5-DSA formed sta-
ble aggregates and that the lipid rafts micodomain are damaged by
the CD. Moreover, this work shows that the membrane microvis-
cosity is directly linked to the cholesterol content of the cell. Inter-
estingly, based on our ESR results, Rameb appears as efﬁcient agent
to extract cholesterol depending on time and concentration. In
summary, this study has demonstrated that ESR is an easy and
reproducible tool able to give a lot of information on the ability
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